The measurement of cardiac output (CO) is essential in medical practice. In the past, invasive monitoring with a pulmonary artery catheter (PAC) was the gold standard used to measure CO, but in recent years, many minimally invasive or noninvasive devices have been developed to measure CO. Cardiac output gives information about tissue perfusion and oxygen delivery and can identify patients at high risk of mortality or morbidity. The non-invasive cardiac output monitoring device market growth is mainly attributed to factors such as increase in prevalence of cardiovascular diseases and rise in geriatric population.
This report contains market size and forecasts of Non-Invasive Cardiac Output Monitoring Device in Global, including the following market information:
Global Non-Invasive Cardiac Output Monitoring Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-Invasive Cardiac Output Monitoring Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Probes and Catheters Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Invasive Cardiac Output Monitoring Device include Baxter, Bio-Beat, General Electric Company., Koninklijke Philips N.V., Abbott, Deltex Medical Limited, NIMedical, LiDCO Ltd. and Conmed Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Invasive Cardiac Output Monitoring Device companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Invasive Cardiac Output Monitoring Device Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-Invasive Cardiac Output Monitoring Device Market Segment Percentages, by Type, 2021 (%)
Probes and Catheters
Patches
Wristwatches
Global Non-Invasive Cardiac Output Monitoring Device Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Non-Invasive Cardiac Output Monitoring Device Market Segment Percentages, by Application, 2021 (%)
Hospitals
Emergency Services Centers
Homecare
Others
Global Non-Invasive Cardiac Output Monitoring Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Non-Invasive Cardiac Output Monitoring Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Invasive Cardiac Output Monitoring Device revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-Invasive Cardiac Output Monitoring Device revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
Bio-Beat
General Electric Company.
Koninklijke Philips N.V.
Abbott
Deltex Medical Limited
NIMedical
LiDCO Ltd.
Conmed Corporation
Imacor